CA2490999A1 - Systemes et procedes d'evaluation non invasive d'un tissu cardiaque, et parametres s'y rapportant - Google Patents
Systemes et procedes d'evaluation non invasive d'un tissu cardiaque, et parametres s'y rapportant Download PDFInfo
- Publication number
- CA2490999A1 CA2490999A1 CA002490999A CA2490999A CA2490999A1 CA 2490999 A1 CA2490999 A1 CA 2490999A1 CA 002490999 A CA002490999 A CA 002490999A CA 2490999 A CA2490999 A CA 2490999A CA 2490999 A1 CA2490999 A1 CA 2490999A1
- Authority
- CA
- Canada
- Prior art keywords
- tissue
- acoustic
- target
- ultrasound
- mode
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 172
- 210000005003 heart tissue Anatomy 0.000 title abstract description 84
- 238000006073 displacement reaction Methods 0.000 claims abstract description 119
- 238000002604 ultrasonography Methods 0.000 claims abstract description 117
- 230000000747 cardiac effect Effects 0.000 claims abstract description 87
- 230000002107 myocardial effect Effects 0.000 claims abstract description 54
- 230000004872 arterial blood pressure Effects 0.000 claims description 54
- 230000036772 blood pressure Effects 0.000 claims description 45
- 230000005855 radiation Effects 0.000 claims description 37
- 230000008859 change Effects 0.000 claims description 26
- 238000003384 imaging method Methods 0.000 claims description 25
- 210000004204 blood vessel Anatomy 0.000 claims description 24
- 230000010355 oscillation Effects 0.000 claims description 22
- 230000001939 inductive effect Effects 0.000 claims description 11
- 230000001766 physiological effect Effects 0.000 claims description 10
- 230000005540 biological transmission Effects 0.000 claims description 9
- 230000002123 temporal effect Effects 0.000 claims description 6
- 230000000241 respiratory effect Effects 0.000 claims description 5
- 230000006698 induction Effects 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 abstract description 239
- 230000002861 ventricular Effects 0.000 abstract description 66
- 230000006870 function Effects 0.000 abstract description 29
- 230000004044 response Effects 0.000 abstract description 18
- 230000001746 atrial effect Effects 0.000 abstract description 15
- 230000003205 diastolic effect Effects 0.000 abstract description 13
- 230000007574 infarction Effects 0.000 abstract description 9
- 208000031225 myocardial ischemia Diseases 0.000 abstract description 9
- 208000010125 myocardial infarction Diseases 0.000 abstract description 6
- 210000002318 cardia Anatomy 0.000 abstract 1
- 238000005259 measurement Methods 0.000 description 62
- 210000004369 blood Anatomy 0.000 description 45
- 239000008280 blood Substances 0.000 description 45
- 210000004556 brain Anatomy 0.000 description 41
- 210000002216 heart Anatomy 0.000 description 28
- 238000003491 array Methods 0.000 description 23
- 238000001514 detection method Methods 0.000 description 23
- 238000002559 palpation Methods 0.000 description 22
- 239000000523 sample Substances 0.000 description 21
- 239000012530 fluid Substances 0.000 description 20
- 230000033001 locomotion Effects 0.000 description 18
- 206010052337 Diastolic dysfunction Diseases 0.000 description 17
- 230000008602 contraction Effects 0.000 description 17
- 210000005013 brain tissue Anatomy 0.000 description 15
- 230000001965 increasing effect Effects 0.000 description 14
- 210000002837 heart atrium Anatomy 0.000 description 13
- 238000012545 processing Methods 0.000 description 13
- 239000000463 material Substances 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 11
- 230000007423 decrease Effects 0.000 description 10
- 210000001147 pulmonary artery Anatomy 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 229910052451 lead zirconate titanate Inorganic materials 0.000 description 9
- 238000012544 monitoring process Methods 0.000 description 9
- 210000003205 muscle Anatomy 0.000 description 9
- 210000004165 myocardium Anatomy 0.000 description 9
- 230000008512 biological response Effects 0.000 description 8
- 238000003745 diagnosis Methods 0.000 description 8
- 230000003534 oscillatory effect Effects 0.000 description 8
- 210000005241 right ventricle Anatomy 0.000 description 8
- 235000015278 beef Nutrition 0.000 description 7
- 238000007906 compression Methods 0.000 description 7
- 230000006835 compression Effects 0.000 description 7
- 238000002592 echocardiography Methods 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 7
- 238000012285 ultrasound imaging Methods 0.000 description 7
- 210000001367 artery Anatomy 0.000 description 6
- 238000009530 blood pressure measurement Methods 0.000 description 6
- 238000007914 intraventricular administration Methods 0.000 description 6
- 208000028867 ischemia Diseases 0.000 description 6
- 210000005240 left ventricle Anatomy 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 206010061216 Infarction Diseases 0.000 description 5
- 230000001133 acceleration Effects 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 230000007613 environmental effect Effects 0.000 description 5
- 230000000004 hemodynamic effect Effects 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 230000010363 phase shift Effects 0.000 description 5
- 230000002269 spontaneous effect Effects 0.000 description 5
- 230000001360 synchronised effect Effects 0.000 description 5
- 230000002792 vascular Effects 0.000 description 5
- 210000003462 vein Anatomy 0.000 description 5
- JRWZLRBJNMZMFE-UHFFFAOYSA-N Dobutamine Chemical compound C=1C=C(O)C(O)=CC=1CCNC(C)CCC1=CC=C(O)C=C1 JRWZLRBJNMZMFE-UHFFFAOYSA-N 0.000 description 4
- 206010019280 Heart failures Diseases 0.000 description 4
- 206010020919 Hypervolaemia Diseases 0.000 description 4
- 206010021137 Hypovolaemia Diseases 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 229960001089 dobutamine Drugs 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 238000009527 percussion Methods 0.000 description 4
- 230000029058 respiratory gaseous exchange Effects 0.000 description 4
- 230000001052 transient effect Effects 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000013500 data storage Methods 0.000 description 3
- 230000003292 diminished effect Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 210000004115 mitral valve Anatomy 0.000 description 3
- 238000012806 monitoring device Methods 0.000 description 3
- 238000012014 optical coherence tomography Methods 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- 238000011265 2D-echocardiography Methods 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 208000009378 Low Cardiac Output Diseases 0.000 description 2
- 238000004497 NIR spectroscopy Methods 0.000 description 2
- 206010037368 Pulmonary congestion Diseases 0.000 description 2
- 206010037423 Pulmonary oedema Diseases 0.000 description 2
- 206010071436 Systolic dysfunction Diseases 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000008321 arterial blood flow Effects 0.000 description 2
- 238000013528 artificial neural network Methods 0.000 description 2
- 230000010455 autoregulation Effects 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 238000002059 diagnostic imaging Methods 0.000 description 2
- 230000010339 dilation Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 208000012866 low blood pressure Diseases 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 210000005171 mammalian brain Anatomy 0.000 description 2
- 238000013178 mathematical model Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 210000003657 middle cerebral artery Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004118 muscle contraction Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 238000002600 positron emission tomography Methods 0.000 description 2
- 230000001902 propagating effect Effects 0.000 description 2
- 208000005333 pulmonary edema Diseases 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 230000000451 tissue damage Effects 0.000 description 2
- 231100000827 tissue damage Toxicity 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010003162 Arterial injury Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 206010048782 Breast calcifications Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000004434 Calcinosis Diseases 0.000 description 1
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010016803 Fluid overload Diseases 0.000 description 1
- 206010018092 Generalised oedema Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 244000081841 Malus domestica Species 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 241000287181 Sturnus vulgaris Species 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000012814 acoustic material Substances 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 210000004712 air sac Anatomy 0.000 description 1
- 208000024783 anasarca Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000035559 beat frequency Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229940124645 emergency medicine Drugs 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000007542 hardness measurement Methods 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 210000001308 heart ventricle Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000000297 inotrophic effect Effects 0.000 description 1
- 239000004041 inotropic agent Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- HFGPZNIAWCZYJU-UHFFFAOYSA-N lead zirconate titanate Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Zr+4].[Pb+2] HFGPZNIAWCZYJU-UHFFFAOYSA-N 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000007620 mathematical function Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 210000002464 muscle smooth vascular Anatomy 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- 210000000107 myocyte Anatomy 0.000 description 1
- 238000013421 nuclear magnetic resonance imaging Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000008560 physiological behavior Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000131 polyvinylidene Polymers 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000010408 sweeping Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000007794 visualization technique Methods 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/48—Diagnostic techniques
- A61B8/485—Diagnostic techniques involving measuring strain or elastic properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/06—Measuring blood flow
- A61B8/065—Measuring blood flow to determine blood output from the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0883—Detecting organic movements or changes, e.g. tumours, cysts, swellings for diagnosis of the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/45—For evaluating or diagnosing the musculoskeletal system or teeth
- A61B5/4519—Muscles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/503—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/504—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of blood vessels, e.g. by angiography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/04—Measuring blood pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0808—Detecting organic movements or changes, e.g. tumours, cysts, swellings for diagnosis of the brain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0891—Detecting organic movements or changes, e.g. tumours, cysts, swellings for diagnosis of blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/42—Details of probe positioning or probe attachment to the patient
- A61B8/4209—Details of probe positioning or probe attachment to the patient by using holders, e.g. positioning frames
- A61B8/4236—Details of probe positioning or probe attachment to the patient by using holders, e.g. positioning frames characterised by adhesive patches
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Abstract
L'invention concerne des systèmes et des procédés d'évaluation non invasive des propriétés d'un tissu cardiaque et de paramètres cardiaques par des techniques faisant appel aux ultrasons. Des déterminations concernant la rigidité, la tension, la dilatation, la vitesse de dilatation et analogue du tissu myocardique peuvent être utilisées pour évaluer la contractilité myocardique, l'ischémie myocardique et l'infarctus du myocarde, la pression de remplissage des ventricules et de l'oreillette, et les fonctions diastoliques. L'invention concerne également des systèmes non invasifs dans lesquels des techniques acoustiques, telles que des techniques mises en oeuvre par ultrasons, sont utilisées pour acquérir des données relatives à des déplacements de tissu intrinsèque. L'invention concerne en outre des systèmes non invasifs dans lesquels des techniques faisant appel aux ultrasons sont utilisées pour stimuler ou palper acoustiquement un tissu cardiaque cible, ou pour induire, au niveau d'un site cardiaque, une réponse se rapportant à des propriétés du tissu cardiaque et/ou des paramètres cardiaques.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39329302P | 2002-07-01 | 2002-07-01 | |
| US60/393,293 | 2002-07-01 | ||
| US47580303P | 2003-06-03 | 2003-06-03 | |
| US60/475,803 | 2003-06-03 | ||
| PCT/US2003/020764 WO2004002305A2 (fr) | 2002-07-01 | 2003-07-01 | Systemes et procedes d'evaluation non invasive d'un tissu cardiaque, et parametres s'y rapportant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2490999A1 true CA2490999A1 (fr) | 2004-01-08 |
Family
ID=30003310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002490999A Abandoned CA2490999A1 (fr) | 2002-07-01 | 2003-07-01 | Systemes et procedes d'evaluation non invasive d'un tissu cardiaque, et parametres s'y rapportant |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1531725A4 (fr) |
| JP (1) | JP2005532097A (fr) |
| AU (1) | AU2003280416A1 (fr) |
| CA (1) | CA2490999A1 (fr) |
| WO (1) | WO2004002305A2 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112165901A (zh) * | 2018-05-29 | 2021-01-01 | 国立大学法人爱媛大学 | 计算机程序、图像处理装置、以及图像处理方法 |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2539414A1 (fr) * | 2003-06-03 | 2004-12-16 | Allez Physionix Limited | Systemes et procedes permettant de determiner la pression intracranienne de facon non invasive et ensembles de transducteurs acoustiques destines a etre utilises dans ces systemes |
| EP1768567A4 (fr) * | 2004-05-07 | 2007-12-05 | Univ Johns Hopkins | Therapies d'imagerie de tissus par ultrasons sous contrainte |
| US7573627B2 (en) | 2004-07-27 | 2009-08-11 | The George Washington University | Amplified bimorph scanning mirror, optical system and method of scanning |
| US7744535B2 (en) * | 2004-07-30 | 2010-06-29 | Wisconsin Alumni Research Foundation | Method and apparatus for acoustoelastic extraction of strain and material properties |
| CA2617622C (fr) * | 2004-08-27 | 2016-05-31 | Verathon Inc. | Systemes et procedes de quantification et de classification de fluides de cavites humaines dans des images ultrasonores |
| FR2875695B1 (fr) * | 2004-09-28 | 2006-12-01 | Echosens Sa | Instrument de mesure de l'elasticite d'un organe du type comportant un moyen de centrage |
| US20060100518A1 (en) * | 2004-10-21 | 2006-05-11 | Sriram Krishnan | Automated diastolic function analysis with ultrasound |
| WO2007022505A2 (fr) * | 2005-08-19 | 2007-02-22 | Visualsonics Inc. | Systèmes et procédés de capture et d’affichage de la pression sanguine et de données par ultrasons |
| US7999945B2 (en) | 2007-07-18 | 2011-08-16 | The George Washington University | Optical coherence tomography / acoustic radiation force imaging probe |
| US10492854B2 (en) | 2007-12-05 | 2019-12-03 | Biosense Webster, Inc. | Catheter-based acoustic radiation force impulse system |
| JP5159326B2 (ja) * | 2008-01-10 | 2013-03-06 | 株式会社東芝 | 超音波診断装置 |
| KR101060345B1 (ko) * | 2008-08-22 | 2011-08-29 | 삼성메디슨 주식회사 | Ａｒｆｉ를 이용하여 탄성영상을 형성하는 초음파 시스템 및 방법 |
| US9364194B2 (en) | 2008-09-18 | 2016-06-14 | General Electric Company | Systems and methods for detecting regions of altered stiffness |
| WO2010125485A1 (fr) * | 2009-05-01 | 2010-11-04 | Koninklijke Philips Electronics, N.V. | Système d'imagerie médicale acoustique et procédé de fonctionnement associé |
| US9168021B2 (en) * | 2009-06-04 | 2015-10-27 | Super Sonic Imagine | Method and apparatus for measuring heart contractility |
| JP5927908B2 (ja) * | 2011-12-27 | 2016-06-01 | セイコーエプソン株式会社 | 血圧計測装置及び血圧計測装置の制御方法 |
| JP2013252423A (ja) * | 2012-05-08 | 2013-12-19 | Seiko Epson Corp | 心拍出量モニター装置および心拍出量測定方法 |
| JP6646646B2 (ja) * | 2014-07-17 | 2020-02-14 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 筋肉の機能パラメータを入手する方法、装置及びシステム |
| JP6412275B2 (ja) * | 2014-10-17 | 2018-10-24 | ユニバーシティ オブ ワシントンＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｗａｓｈｉｎｇｔｏｎ | 広範集束超音波推進プローブ、システム、及び方法 |
| JP6553210B2 (ja) * | 2015-01-15 | 2019-07-31 | ハーリング、ロドニー | 拡散音響共焦点撮像装置 |
| GB201519985D0 (en) * | 2015-11-12 | 2015-12-30 | Respinor As | Ultrasonic method and apparatus for respiration monitoring |
| KR102624614B1 (ko) * | 2018-03-21 | 2024-01-15 | 삼성메디슨 주식회사 | 초음파 진단 장치 및 그 제어 방법 |
| US20220079550A1 (en) * | 2018-12-20 | 2022-03-17 | Koninklijke Philips N.V. | Methods and systems for monitoring a function of a heart |
| EP3685756A1 (fr) * | 2019-01-24 | 2020-07-29 | Koninklijke Philips N.V. | Procédés et systèmes permettant d'étudier des caractéristiques de vaisseau sanguin |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5474070A (en) * | 1989-11-17 | 1995-12-12 | The Board Of Regents Of The University Of Texas System | Method and apparatus for elastographic measurement and imaging |
| US5524636A (en) * | 1992-12-21 | 1996-06-11 | Artann Corporation Dba Artann Laboratories | Method and apparatus for elasticity imaging |
| DE19524880C2 (de) * | 1994-07-15 | 2000-09-21 | Agilent Technologies Inc | Endokardiale Echtzeit-Ultraschallverschiebungsanzeige |
| WO1998055025A1 (fr) * | 1997-06-02 | 1998-12-10 | Duke University | Dispositif et methode pour examen oculaire acoustique cinetique |
| US6352509B1 (en) * | 1998-11-16 | 2002-03-05 | Kabushiki Kaisha Toshiba | Three-dimensional ultrasonic diagnosis apparatus |
| US6352507B1 (en) * | 1999-08-23 | 2002-03-05 | G.E. Vingmed Ultrasound As | Method and apparatus for providing real-time calculation and display of tissue deformation in ultrasound imaging |
| US6527717B1 (en) * | 2000-03-10 | 2003-03-04 | Acuson Corporation | Tissue motion analysis medical diagnostic ultrasound system and method |
| US6328694B1 (en) * | 2000-05-26 | 2001-12-11 | Inta-Medics, Ltd | Ultrasound apparatus and method for tissue resonance analysis |
| CA2428872C (fr) * | 2000-11-28 | 2013-01-08 | Allez Physionix Limited | Systemes et procedes de mise oeuvre d'evaluations physiologiques non effractives |
-
2003
- 2003-07-01 CA CA002490999A patent/CA2490999A1/fr not_active Abandoned
- 2003-07-01 EP EP03742372A patent/EP1531725A4/fr not_active Withdrawn
- 2003-07-01 JP JP2004518187A patent/JP2005532097A/ja active Pending
- 2003-07-01 AU AU2003280416A patent/AU2003280416A1/en not_active Abandoned
- 2003-07-01 WO PCT/US2003/020764 patent/WO2004002305A2/fr active Application Filing
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112165901A (zh) * | 2018-05-29 | 2021-01-01 | 国立大学法人爱媛大学 | 计算机程序、图像处理装置、以及图像处理方法 |
| CN112165901B (zh) * | 2018-05-29 | 2024-04-05 | 国立大学法人爱媛大学 | 计算机可读记录介质、图像处理装置、以及图像处理方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1531725A4 (fr) | 2009-02-04 |
| EP1531725A2 (fr) | 2005-05-25 |
| WO2004002305A2 (fr) | 2004-01-08 |
| AU2003280416A8 (en) | 2004-01-19 |
| JP2005532097A (ja) | 2005-10-27 |
| AU2003280416A1 (en) | 2004-01-19 |
| WO2004002305A3 (fr) | 2004-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7815574B2 (en) | Systems and methods for determining blood pressure | |
| US6875176B2 (en) | Systems and methods for making noninvasive physiological assessments | |
| CA2490999A1 (fr) | Systemes et procedes d'evaluation non invasive d'un tissu cardiaque, et parametres s'y rapportant | |
| US20060079773A1 (en) | Systems and methods for making non-invasive physiological assessments by detecting induced acoustic emissions | |
| Pernot et al. | Real-time assessment of myocardial contractility using shear wave imaging | |
| US6358208B1 (en) | Assessment of cardiovascular performance using ultrasound methods and devices that interrogate interstitial fluid | |
| US7547283B2 (en) | Methods for determining intracranial pressure non-invasively | |
| JP3875581B2 (ja) | 超音波診断システム | |
| Seo et al. | Noninvasive arterial blood pressure waveform monitoring using two-element ultrasound system | |
| US6659949B1 (en) | Technique to measure capillary related interstitial fluid using ultra-sonic methods and devices | |
| EP2392262A1 (fr) | Procédés et systèmes pour localiser et illuminer acoustiquement une zone cible souhaitée | |
| Huang et al. | Continuous measurement of arterial diameter using wearable and flexible ultrasonic sensor | |
| US20220068481A1 (en) | Methods and system for obtaining a physiological measure from a subject | |
| US20220240804A1 (en) | Method and apparatus for noninvasive absolute (mean) intracranial pressure (a-icp) measurement and/or monitoring | |
| US20210259666A1 (en) | System and method for non-invasive real time assessment of cardiovascular blood pressure | |
| Seo | A non-invasive central arterial pressure waveform estimation system using ultrasonography for real-time monitoring | |
| EP4371475A1 (fr) | Mesure sans fil de dimensions intracorporelles pour la surveillance et le diagnostic de patients | |
| Li | Bionic Age Hemodynamic Monitoring: Invasive, Non-invasive, Wearable, and Wireless Applications | |
| Aristizabal et al. | Application of guided waves for quantifying elasticity and viscoelasticity of boundary sensitive organs | |
| Gross et al. | Measuring cardiac function |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |
Effective date: 20130128 |